Miaoshou Doctor: Chinese healthtech firm Yuanxin rakes in $232m from Sequoia China, others

Beijing Yuanxin Technology Co, which runs the pharmaceutical e-commerce platform Miaoshou Doctor in China, announced on Tuesday the completion of a Series F round at over 1.5 billion yuan ($232.1 million) from investors including Sequoia Capital China.